Kim Hyong sold $714K of ALHC
Kim Hyong (Chief Medical Officer) sold 35,951 shares of Alignment Healthcare, Inc. (ALHC) at $19.86 ($0.71M total) on 2026-06-12 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific sale size, price, and that it was executed under a pre-arranged 10b5-1 plan, which generally limits interpretive impact.
Market read
This provides a fresh, primary-source datapoint on insider activity but lacks any accompanying fundamental catalyst.
What to watch
Traders may over-weight insider sales; without accompanying guidance, trial, or contract news, the disclosure is unlikely to change valuation drivers.
Background
The article is an SEC Form 4 insider transaction disclosure for Alignment Healthcare, Inc.
Ticker impact
Alignment Healthcare CMO Kim Hyong filed an open-market sale of 35,951 shares under a pre-arranged 10b5-1 plan.
Likely limited near-term impact; any reaction should be small unless accompanied by other company-specific catalysts.
The disclosure is a routine Form 4 open-market sale with an explicitly pre-arranged 10b5-1 plan, which typically dampens interpretive value versus discretionary selling.
Market effects
No direct sector read-through; this is a single-company insider transaction without operational or regulatory updates.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than a negative view on fundamentals.
Key entities
- issuerAlignment Healthcare, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderKim Hyong
Chief Medical Officer who sold 35,951 shares in an open-market transaction.
